T cell exclusion, immune privilege, and the tumor microenvironment (Q28259872)

https://api.crossref.org/works/10.1126/SCIENCE.AAA6204

Cancer immunoediting: integrating immunity's roles in cancer suppression and promotion

20 April 2017

1 reference

https://api.crossref.org/works/10.1126/SCIENCE.AAA6204

Durable complete responses in heavily pretreated patients with metastatic melanoma using T-cell transfer immunotherapy

20 April 2017

1 reference

https://api.crossref.org/works/10.1126/SCIENCE.AAA6204

Improved Survival with Ipilimumab in Patients with Metastatic Melanoma

20 April 2017

1 reference

https://api.crossref.org/works/10.1126/SCIENCE.AAA6204

Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer

20 April 2017

1 reference

https://api.crossref.org/works/10.1126/SCIENCE.AAA6204

Safety, activity, and immune correlates of anti-PD-1 antibody in cancer

20 April 2017

1 reference

https://api.crossref.org/works/10.1126/SCIENCE.AAA6204

The future of immune checkpoint therapy

20 April 2017

1 reference

https://api.crossref.org/works/10.1126/SCIENCE.AAA6204

Fc-dependent depletion of tumor-infiltrating regulatory T cells co-defines the efficacy of anti-CTLA-4 therapy against melanoma

20 April 2017

1 reference

https://api.crossref.org/works/10.1126/SCIENCE.AAA6204

Type, density, and location of immune cells within human colorectal tumors predict clinical outcome

20 April 2017

1 reference

https://api.crossref.org/works/10.1126/SCIENCE.AAA6204

Batf3 Deficiency Reveals a Critical Role for CD8 + Dendritic Cells in Cytotoxic T Cell Immunity

20 April 2017

1 reference

https://api.crossref.org/works/10.1126/SCIENCE.AAA6204

Engineered SIRPα variants as immunotherapeutic adjuvants to anticancer antibodies

20 April 2017

1 reference

https://api.crossref.org/works/10.1126/SCIENCE.AAA6204

Active movement of T cells away from a chemokine

20 April 2017

1 reference

https://api.crossref.org/works/10.1126/SCIENCE.AAA6204

Accessories to the crime: functions of cells recruited to the tumor microenvironment

20 April 2017

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.AAA6204

Regulatory T cells: mechanisms of differentiation and function

20 April 2017

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.AAA6204

Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer

20 April 2017

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.AAA6204

Leukocyte complexity predicts breast cancer survival and functionally regulates response to chemotherapy

20 April 2017

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.AAA6204

Macrophage diversity enhances tumor progression and metastasis

20 April 2017

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.AAA6204

CD40 agonists alter tumor stroma and show efficacy against pancreatic carcinoma in mice and humans

20 April 2017

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.AAA6204

Microenvironmental regulation of tumor progression and metastasis

20 April 2017

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.AAA6204

ON THE CAUSE OF THE LOCALIZATION OF SECONDARY TUMORS AT POINTS OF INJURY

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.AAA6204

Tumor progression can occur despite the induction of very high levels of self/tumor antigen-specific CD8+ T cells in patients with melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.AAA6204

Adoptive cell transfer as personalized immunotherapy for human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.AAA6204

Infusions of donor leukocytes to treat Epstein-Barr virus-associated lymphoproliferative disorders after allogeneic bone marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.AAA6204

MPDL3280A (anti-PD-L1) treatment leads to clinical activity in metastatic bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.AAA6204

Predictive correlates of response to the anti-PD-L1 antibody MPDL3280A in cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.AAA6204

PD-1 blockade induces responses by inhibiting adaptive immune resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.AAA6204

A rheostat for immune responses: the unique properties of PD-1 and their advantages for clinical application

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.AAA6204

Strength of PD-1 signaling differentially affects T-cell effector functions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.AAA6204

Intraepithelial CD8+ tumor-infiltrating lymphocytes and a high CD8+/regulatory T cell ratio are associated with favorable prognosis in ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.AAA6204

Targeting CXCL12 from FAP-expressing carcinoma-associated fibroblasts synergizes with anti-PD-L1 immunotherapy in pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.AAA6204

Monocytic CCR2(+) myeloid-derived suppressor cells promote immune escape by limiting activated CD8 T-cell infiltration into the tumor microenvironment

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.AAA6204

Tumor-derived granulocyte-macrophage colony-stimulating factor regulates myeloid inflammation and T cell immunity in pancreatic cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.AAA6204

Oncogenic Kras-induced GM-CSF production promotes the development of pancreatic neoplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.AAA6204

CSF1R inhibition delays cervical and mammary tumor growth in murine models by attenuating the turnover of tumor-associated macrophages and enhancing infiltration by CD8(+) T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.AAA6204

CSF1/CSF1R blockade reprograms tumor-infiltrating macrophages and improves response to T-cell checkpoint immunotherapy in pancreatic cancer models.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.AAA6204

Pten null prostate epithelium promotes localized myeloid-derived suppressor cell expansion and immune suppression during tumor initiation and progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.AAA6204

Chemokine nitration prevents intratumoral infiltration of antigen-specific T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.AAA6204

Tumor endothelium FasL establishes a selective immune barrier promoting tolerance in tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.AAA6204

Tumor associated endothelial expression of B7-H3 predicts survival in ovarian carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.AAA6204

Endothelin B receptor mediates the endothelial barrier to T cell homing to tumors and disables immune therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.AAA6204

Vascular normalization as an emerging strategy to enhance cancer immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.AAA6204

Antiangiogenic therapy--evolving view based on clinical trial results.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.AAA6204

Antiangiogenic agents can increase lymphocyte infiltration into tumor and enhance the effectiveness of adoptive immunotherapy of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.AAA6204

Vascular normalizing doses of antiangiogenic treatment reprogram the immunosuppressive tumor microenvironment and enhance immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.AAA6204

Tumor-targeted TNFα stabilizes tumor vessels and enhances active immunotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.AAA6204

Tumor masses support naive T cell infiltration, activation, and differentiation into effectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.AAA6204

CCL2/CCR2-dependent recruitment of functional antigen-presenting cells into tumors upon chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.AAA6204

Dissecting the tumor myeloid compartment reveals rare activating antigen-presenting cells critical for T cell immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.AAA6204

Macrophage IL-10 blocks CD8+ T cell-dependent responses to chemotherapy by suppressing IL-12 expression in intratumoral dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.AAA6204

Targeting the tumor microenvironment with interferon-β bridges innate and adaptive immune responses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.AAA6204

PD-L1 is a novel direct target of HIF-1α, and its blockade under hypoxia enhanced MDSC-mediated T cell activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.AAA6204

Functional polarization of tumour-associated macrophages by tumour-derived lactic acid.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.AAA6204

KIT oncogene inhibition drives intratumoral macrophage M2 polarization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.AAA6204

Macrophage activation and polarization: nomenclature and experimental guidelines

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.AAA6204

Indoleamine 2,3 dioxygenase and metabolic control of immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.AAA6204

Tryptophan catabolism in cancer: beyond IDO and tryptophan depletion

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.AAA6204

IDO is a nodal pathogenic driver of lung cancer and metastasis development

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.AAA6204

Indoleamine 2,3-dioxygenase is a critical resistance mechanism in antitumor T cell immunotherapy targeting CTLA-4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.AAA6204

An inherently bifunctional subset of Foxp3+ T helper cells is controlled by the transcription factor eos.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.AAA6204

In vivo discovery of immunotherapy targets in the tumour microenvironment

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.AAA6204

CSF-1R inhibition alters macrophage polarization and blocks glioma progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.AAA6204

B cells regulate macrophage phenotype and response to chemotherapy in squamous carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.AAA6204

Inflammatory monocytes are potent antitumor effectors controlled by regulatory CD4+ T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.AAA6204

The CD47-SIRPα signalling system: its physiological roles and therapeutic application

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.AAA6204

Matrix architecture defines the preferential localization and migration of T cells into the stroma of human lung tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.AAA6204

Suppression of antitumor immunity by stromal cells expressing fibroblast activation protein-alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.AAA6204

Depletion of stromal cells expressing fibroblast activation protein-α from skeletal muscle and bone marrow results in cachexia and anemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.AAA6204

Vitamin D receptor-mediated stromal reprogramming suppresses pancreatitis and enhances pancreatic cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.AAA6204

Prognostic significance of CXCL12 expression in patients with colorectal carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.AAA6204

Tumor cells disseminate early, but immunosurveillance limits metastatic outgrowth, in a mouse model of melanoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.AAA6204

Changes in the local tumor microenvironment in recurrent cancers may explain the failure of vaccines after surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.AAA6204

Targeting TNF- to Neoangiogenic Vessels Enhances Lymphocyte Infiltration in Tumors and Increases the Therapeutic Potential of Immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.AAA6204

Phase 2 Trial of Single Agent Ipilimumab (Anti-CTLA-4) for Locally Advanced or Metastatic Pancreatic Adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.AAA6204

Vascular normalization in Rgs5-deficient tumours promotes immune destruction

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.AAA6204